SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Profiteer who wrote (3844)9/1/1998 8:53:00 PM
From: Profiteer  Read Replies (1) of 5402
 
This post is from the COII thread but I think it demonstrates how important new drugs, possibly including PHER-02 are viewed by the FDA now days.

Encouraging news that the FDA is willing to help all it can in life saving technologies and drugs. It was announced that the FDA was putting the experimental drug, Hercepton on their Fast-Track. The drug targets defective genes in late stages of breast cancer..
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News